Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis

BACKGROUND: Clinical guidelines recommend a stepped-escalation treatment strategy for type 2 diabetes (T2DM). Across multiple treatment strategies varying in efficacy and costs, no clinical or economic studies directly compared them. This study aims to estimate and compare the cost-effectiveness of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Shuyan, Shi, Lizheng, Shao, Hui, Wang, Xiaoyong, Hu, Xiaoqian, Gu, Yuxuan, Dong, Hengjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713153/
https://www.ncbi.nlm.nih.gov/pubmed/33267884
http://dx.doi.org/10.1186/s12916-020-01837-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713153/
https://www.ncbi.nlm.nih.gov/pubmed/33267884
http://dx.doi.org/10.1186/s12916-020-01837-x

Ejemplares similares